The Angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

Biochemical and Biophysical Research Communications

Volumn 236, Issue 3, 1997, Pages 622-625

  Keidar, Shlomo ^a   Attias, Judith ^a   Smith, Jonathan ^b   Breslow, Jan L ^b   Hayek, Tony ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN E; COPPER SULFATE; LOSARTAN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PLACEBO; RENIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANIMALIA;

EID: 0031591667     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6844     Document Type: Article

References (38)

1. Crozier I., Ikram H., Awan N. Circulation. 91:1995;691.
2. Gottlieb S., Dickstein K., Fleck E. Circulation. 88:1993;1602.
3. Geisterfer A., Peach M., Owens G. Circ. Res. 62:1988;749.
4. Campbell-Boswell M., Roberston A. Exp. Mol. Pathol. 35:1981;265.
5. Daemon M., Lombardi D., Bosman F., Shwartz S. Circ. Res. 68:1991;450.
6. Wolf G., Haberstroh U., Neilson E. Am. J. Pathol. 140:1992;95.
7. Katoh H., Suzuki H., Ogata Y. Clin. Exp. Hypertension. 12:1990;675.
8. Chobanian A., Handenschild C., Nickerson C., Drago K. Hypertension. 15:1990;327.
9. Aberg G., Ferrer P. J. Cardiovas. Pharmacol. 15:1990;565.
10. Charpiot P., Rolland P., Friggi A. Arterioscler. Throm. 13:1993;1125.
11. Rolland P., Souchet T., Friggi A. J. Hypertension. 9:1991;S178.
12. Kowala M., Grove R., Aberg G. Atherosclerosis. 108:1994;61.
13. Griffin S., Brown W., Lever A. Hypertension. 17:1991;626.
14. Hayek T., Oiknin J., Breslow J., Keidar S. Circulation. 92:1995;2998.
15. Israeli Z., Hall W. Ann. Intern. Med. 117:1992;234.
16. Lacourciere Y., Brunne H., Irwin R. J. Hypertension. 12:1994;1387.
17. Timmermans P., Wong P., Chiu A. Pharmacol. Rev. 45:1993;205.
18. Urata H., Boehm K., Philip A. J. Clin. Invest. 91:1993;1269.
19. Aviram M. Atherosclerosis. 98:1993;1.
20. Witztum J., Steinberg D. J. Clin. Invest. 88:1991;1785.
21. Plump A., Smith J., Hayek T., Breslow J. Cell. 71:1992;343.
22. Zhang S., Reddick R., Maeda N. Science. 258:1992;468.
23. Nakashima Y., Plump A., Raines E., Breslow J., Ross R. Arterioscler. Thromb. 14:1994;133.
24. Reddick R., Zhang S., Maeda N. Arterioscler. Thromb. 14:1994;141.
25. Hayek T., Oiknine J., Brook J. G., Aviram M. Biochem. Biophys. Res. Com. 201:1994;1567.
26. Walsh A., Ito Y., Breslow J. L. J. Biol. Chem. 264:1989;6488.
27. Lowry O. H., Rosebrough N., Randall R. J. Biol. Chem. 193:1951;265.
28. Buege L., Aust S. Methods Enzymol. 52:1978;302.
29. Keidar S., Kaplan M., Hoffman A., Brook J. G., Aviram M. Atherosclerosis. 115:1995;201.
30. Keidar S., Brook J. G., Aviram M. News Physiol. Sci. 8:1993;245.
31. Goodfriend T., Elliott M., Catt K. New Eng. J. Med. 334:1996;1649.
32. Pitt B., Segal R., Chang P. Lancet. 349:1997;747.
33. Sugano M., Makino N., Yanaga T. Atherosclerosis. 127:1996;123.
34. Schuh J., Blehm D., Frierdich G., Blaine E. J. Clin. Invest. 91:1993;1453.
35. Jackson B., Cubela R., Johnston C. J. Pharmacol. Exp. Ther. 245:1988;950.
36. Cohen M., Kurz K. J. Pharmacol. Exp. Ther. 220:1982;63.
37. Timmermans P., Smight R. Cardiologia. 39:1994;397.
38. Tanaka M. Ohnishi, Ozawa Y., Naruse M. Biochem. Biophys. Res. Commun. 207:1995;593.